Susquehanna International Group, LLP Celularity Inc Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.17 - $0.33 $1,027 - $1,995	-6,047 Reduced 36.45%	10,543 $2,000
Q3 2023 Nov 14, 2023	SELL	$0.22 - $0.56 $18,733 - $47,686	-85,154 Reduced 83.69%	16,590 $3,000
Q2 2023 Aug 11, 2023	BUY	$0.42 - $0.81 $23,764 - $45,832	56,583 Added 125.29%	101,744 $53,000
Q1 2023 May 16, 2023	BUY	$0.56 - $1.15 $17,759 - $36,469	31,713 Added 235.82%	45,161 $27,000
Q4 2022 Feb 14, 2023	SELL	$1.08 - $2.35 $8,898 - $19,361	-8,239 Reduced 37.99%	13,448 $17,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $4.31 $75,394 - $755,693	-175,335 Reduced 88.99%	21,687 $50,000
Q2 2022 Aug 15, 2022	SELL	$2.81 - $12.91 $142,433 - $654,382	-50,688 Reduced 20.46%	197,022 $670,000
Q1 2022 May 16, 2022	BUY	$3.81 - $9.79 $943,775 - $2.43 Million	247,710 New	247,710 $2.16 Million

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.